# EXHIT ENTRE Comparative Effectiveness Trial

> **NCT04345718** · PHASE2,PHASE3 · COMPLETED · sponsor: **Gavin Bart** · enrollment: 344 (actual)

## Conditions studied

- Substance Use Disorder
- Opioid Use Disorder, Moderate
- Opioid Use Disorder, Severe

## Interventions

- **DRUG:** Extended Release Buprenorphine
- **DRUG:** Treatment as Usual

## Key facts

- **NCT ID:** NCT04345718
- **Lead sponsor:** Gavin Bart
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-09
- **Primary completion:** 2025-08-27
- **Final completion:** 2025-08-27
- **Target enrollment:** 344 (ACTUAL)
- **Last updated:** 2025-12-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04345718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04345718, "EXHIT ENTRE Comparative Effectiveness Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04345718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*